NU SKIN ENTERPRISES, INC.
No SEC Form 4 filings for $NUS in the last 30 days.
See all $NUS insider activity →Nu Skin Enterprises (NUS) is set to report Q2 2026 earnings on Aug. 10 after market close, according to Finnhub. Analysts expect revenue of $348.652M and EPS of $0.20. The article cites Q1 2026 revenue of $320.6M, down 12.04% YoY, plus recent insider sales and institutional 13F changes.
Winett James M sold 7,203 shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.62 on 2026-06-02 under a Rule 10b5-1 trading plan.
WOODBURY EDWINA D sold 7,203 shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.70 on 2026-06-01 under a Rule 10b5-1 trading plan.
Over the past 7 days, alphai's AI scored 1 news story mentioning NUS (NU SKIN ENTERPRISES, INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent NUS coverage spans insider activity, financial news and earnings.
This is a pre-earnings positioning piece for NUS ahead of its Aug 10 after-hours report, using consensus estimates and recent insider/13F activity.
Insider selling is disclosed but tied to a 10b5-1 plan, so it’s typically a low-signal catalyst absent other company-specific news.
The filing is a director selling transaction under a pre-arranged 10b5-1 plan; it’s typically low-signal for fundamentals but can affect near-term sentiment.
The filing of an initial Form 3 by CFO Chelsea Lantz reveals her ownership stake but does not indicate recent trading activity. This information is neutral in terms of immediate market impact.
NUS is adapting to wellness shifts and digital trends to sustain growth.
alphai scores every news story that mentions NUS with an AI model for sentiment and relevance, and aggregates insider trades from NU SKIN ENTERPRISES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Nu Skin Enterprises (NUS) is set to report Q2 2026 earnings on Aug. 10 after market close, according to Finnhub. Analysts expect revenue of $348.652M and EPS of $0.20. The article cites Q1 2026 revenue of $320.6M, down 12.04% YoY, plus recent insider sales and institutional 13F changes.
4 min readWinett James M sold 7,203 shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.62 on 2026-06-02 under a Rule 10b5-1 trading plan.
2 min readWOODBURY EDWINA D sold 7,203 shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.70 on 2026-06-01 under a Rule 10b5-1 trading plan.
1 min readNu Skin Enterprises' Chief Financial Officer, Chelsea K. Lantz, has filed an initial Form 3, disclosing her beneficial ownership of 42,100 shares of Class A Common Stock. This filing establishes her equity position as an executive officer. The Form 3 is an initial statement and does not represent a buy or sell transaction.
2 min readULTA, EL and NUS tap digital innovation, wellness shifts and curated assortments to capture beauty's expanding long-term demand.
4 min read
